MALVERN, Pa. (AP) -- Shares of wireless medical device maker BioTelemetry jumped Monday after the company announced it had prevailed in court — and subsequently acquired — a rival wireless technology ...

Shares of BioTelemetry (NASDAQ: BEAT) rose over 17% today after the company announced second-quarter 2018 earnings. The medical-device manufacturer reported record quarterly earnings of $101.4 million ...

BioTelemetry, Inc. BEAT is set to report third-quarter 2018 results on Oct 30, after market close. The company delivered an earnings surprise of 48.4% in the last reported quarter. BioTelemetry beat ...

BioTelemetry Inc. BEAT reported fourth-quarter 2017 adjusted earnings per share of 32 cents, beating the Zacks Consensus Estimate by 52.4%. Adjusted earnings per share rose 77.8% on a year-over-year ...

The S&P 500 gets clobbered and loses more than 2% while BioTelemetry, GlobalStar, and ArthroCare buck the trend and roar higher. The primary culprit that caused the markets to dive precipitously ...

BIOTELEMETRY ($BEAT) posted quarterly earnings results on Thursday, March 13th. The company reported earnings of -$0.18 per share, beating estimates of -$0.19 by $0. ...

BioTelemetry, a technology company focused on health information delivery, has acquired Telcare, a digital diabetes management platform. Telcare developed the first FDA-cleared cellular enabled blood ...

BioTelemetry (BEAT) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.52 per share a year ago. These figures ...

BioTelemetry gained as much as 18% on Friday after news that the cardiac-diagnostics company will be acquired by Dutch company Royal Philips for $2.8 billion. Shares of BioTelemetry rose from Thursday ...